Why Menopause Counselling Is High-Yield
Around 13 million women in the UK are perimenopausal or postmenopausal, and NICE guidance (NG23) has pushed menopause counselling firmly onto the UKMLA curriculum and OSCE circuits. This station tests two things at once: can you recognise the symptom pattern, and can you counsel on HRT in a balanced, jargon-free way that lets the patient make an informed choice. Examiners mark you down heavily for sounding like you're reciting a leaflet, or for being either dismissive of symptoms or alarmist about risk.
💡 Tip
Before you start, note the patient's age and any red flags in the station brief (postmenopausal bleeding, personal history of breast cancer, unprovoked VTE). These change your entire approach, so check them before you open with a symptom-led question.
Structuring the Consultation
- 1Open with a broad, non-leading question: "Tell me what's been going on."
- 2Screen systematically for the core symptom clusters (below).
- 3Establish the impact on daily life, work, relationships, and sleep, this is what determines whether treatment is indicated, not the symptoms alone.
- 4ICE, especially concerns about cancer risk, which are almost always present but rarely voiced first.
- 5Counsel on options in a structured, balanced way.
- 6Check understanding and agree a shared plan.
Core Symptom Clusters, Use VMS-PSU
🧠 Mnemonic
VMS-PSU for systematic menopause symptom screening:
- Vasomotor (hot flushes, night sweats)
- Mood (low mood, anxiety, irritability, brain fog)
- Sleep disturbance
- Physical (joint aches, headaches, palpitations)
- Sexual (vaginal dryness, dyspareunia, reduced libido, genitourinary syndrome of menopause)
- Urinary (urgency, recurrent UTIs, stress incontinence)
Key questions:
- "How often are the hot flushes or night sweats, and are they affecting your sleep or work?"
- "Have you noticed any changes in your mood, memory, or concentration?"
- "Any dryness, discomfort, or pain during sex?"
- "When did your periods last change, are they becoming irregular, or have they stopped completely?"
💎 Clinical Pearl
A woman is postmenopausal once she has had 12 consecutive months without a period (in the absence of another cause). Perimenopause is the transition period beforehand, often lasting 4–8 years, where symptoms are frequently at their worst due to fluctuating rather than simply falling oestrogen.
Diagnosis, When Do You Need Blood Tests?
⚠️ Red Flag
NICE NG23: In women over 45 with typical vasomotor symptoms, menopause is a clinical diagnosis. FSH testing is not required and can be misleading due to fluctuating levels during perimenopause.
FSH testing is reserved for:
- Women aged 40–45 with menopausal symptoms
- Women under 40 with suspected premature ovarian insufficiency (needs two FSH samples 4–6 weeks apart)
- Women on hormonal contraception where the natural cycle is masked
Counselling on HRT, The Framework
Use a structured "what, why, risks, alternatives" approach, mirroring how you'd counsel on any medication, but tailored to the emotive nature of this decision.
Step 1: What HRT Is
"HRT replaces the oestrogen your ovaries are no longer reliably producing, which is what's driving your symptoms. If you still have a womb, we also give a progestogen to protect the lining of the womb from the effects of oestrogen alone."
Step 2: The Options
| Component | Options | Notes |
|---|---|---|
| Oestrogen | Transdermal (patch, gel, spray) or oral | Transdermal avoids first-pass liver metabolism, no increased VTE or stroke risk |
| Progestogen | Needed if uterus present | Cyclical (if perimenopausal, still having periods) or continuous (if >12 months postmenopausal) |
| Combined options | Mirena IUS + oestrogen | IUS provides progestogen component and contraception |
| Local vaginal oestrogen | Cream, pessary, ring | For genitourinary symptoms alone; safe even alongside systemic HRT or with a history of breast cancer in most cases (discuss with oncology) |
💎 Clinical Pearl
"Do I still need contraception?" is a very common question. HRT is not contraceptive. Women are advised to use contraception until 2 years after their last period if under 50, or 1 year if over 50.
Step 3: Risks and Benefits, in Balanced Language
💡 Tip
Avoid reciting a list of risks flatly, this is where students lose marks. Frame risk in absolute terms and relative to baseline risk, and always pair it with benefit.
- Breast cancer: Combined HRT is associated with a small increased risk, roughly comparable to the increased risk from being overweight or drinking 2 units of alcohol daily. Oestrogen-only HRT carries little to no increased risk. Risk reduces after stopping.
- VTE: Oral oestrogen increases risk; transdermal (patch/gel) does not appear to increase VTE risk above baseline, this is a key discriminating fact examiners look for.
- Cardiovascular disease: HRT started within 10 years of menopause (or under age 60) is not associated with increased cardiovascular risk, and may be protective.
- Benefits: Symptom relief, protection against osteoporosis, and improvement in genitourinary symptoms and quality of life.
Step 4: Contraindications
⚠️ Red Flag
Absolute/major contraindications to systemic HRT:
- Current or past breast cancer, or other oestrogen-sensitive cancer
- Undiagnosed vaginal bleeding
- Untreated endometrial hyperplasia
- Active or recent VTE (unless on anticoagulation and specialist advice)
- Active liver disease with abnormal LFTs
Non-Hormonal Options
Always mention these, some patients cannot or will not take HRT:
- Vasomotor symptoms: SSRIs/SNRIs (e.g. venlafaxine), clonidine, fezolinetant (a newer NK3-receptor antagonist)
- Lifestyle: layered clothing, avoiding triggers (caffeine, alcohol, spicy food), regular exercise, weight management, CBT (NICE-recommended for mood and hot flush distress)
- Vaginal dryness alone: vaginal moisturisers and lubricants, or local vaginal oestrogen (very low systemic absorption)
Red Flags, Never Miss
⚠️ Red Flag
Postmenopausal bleeding (any bleeding after 12 months amenorrhoea, or unscheduled bleeding on HRT beyond the first 3–6 months) requires a two-week-wait referral to exclude endometrial cancer. Do not attribute this to HRT without investigation.
How to Close the Station
- 1Summarise the options discussed.
- 2Check understanding: "What are your thoughts on what we've discussed?"
- 3Avoid pressuring either way, this is a preference-sensitive decision.
- 4Safety-net: "If you notice any bleeding after starting treatment, or anything unusual, please come back and let us know."
- 5Offer written information and a follow-up review at 3 months.
Frequently Asked Questions
"Does HRT cause weight gain?"
There is no strong evidence that HRT itself causes weight gain. Weight changes around menopause are common and are more strongly linked to ageing, reduced muscle mass, and lifestyle changes than to HRT itself.
"How long can I stay on HRT for?"
There is no arbitrary stopping point. The decision to continue is reviewed annually, weighing ongoing symptom control and quality of life against individual risk factors, which change over time.
"I've had a hysterectomy, do I still need a progestogen?"
No. If the uterus has been removed, oestrogen-only HRT is used, since there is no endometrium to protect. This is a discriminating detail examiners often check for.